Hi,
I think the up coming sales figures might surprise and if so
we are away.
Aloha.
- Forums
- ASX - By Stock
- OCC
- Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients, page-43
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
68.5¢ |
Change
0.030(4.58%) |
Mkt cap ! $163.7M |
Open | High | Low | Value | Volume |
67.5¢ | 69.5¢ | 67.0¢ | $539.8K | 794.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1393 | 68.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
68.5¢ | 15395 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1393 | 0.680 |
1 | 10000 | 0.670 |
4 | 40903 | 0.665 |
5 | 57745 | 0.660 |
1 | 5866 | 0.655 |
Price($) | Vol. | No. |
---|---|---|
0.685 | 15395 | 2 |
0.690 | 35140 | 4 |
0.695 | 81000 | 4 |
0.700 | 56449 | 9 |
0.715 | 853 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online